An item on AVI BioPharma Inc. in the Science Scan section of the July 22, 2002, issue of BioWorld Today misspelled the name of the company's antisense platform technology, NeuGene.
Editor's note: The correction has been made in BioWorld Online.
An item on AVI BioPharma Inc. in the Science Scan section of the July 22, 2002, issue of BioWorld Today misspelled the name of the company's antisense platform technology, NeuGene.
Editor's note: The correction has been made in BioWorld Online.
To read more on related topics, click on one of the words below.